Genta Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Berkeley NJ United States (1988)
Status: Defunct (2012)

Organization Overview

First Clinical Trial
2000
NCT00016263
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Genta Incorporated